(Reuters) - The European Medicines Agency, however, said it had taken action on this risk late last year by strengthening warnings on the medicine.
"The situation in Europe is a little bit different to the American situation because, in Europe, Avandia is contraindicated in patients with heart failure anyway and we have warnings about ischemia," an agency spokeswoman said.
Read more at Reuters.com Government Filings News
"The situation in Europe is a little bit different to the American situation because, in Europe, Avandia is contraindicated in patients with heart failure anyway and we have warnings about ischemia," an agency spokeswoman said.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment